Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?

被引：1
|
作者：
Pavlovic, Mira [1 ,2 ]
Garnier, Jerome [3 ]
Durand-Zaleski, Isabelle [4 ,5 ]
Bilbault, Pascal [6 ]
Gaudin, Anne-Francoise [7 ]
Le Jeunne, Claire [8 ]
Lalaude, Olivier [9 ]
Roze, Stephane [10 ]
De Sahb, Rima [11 ]
Sapede, Claudine [12 ]
机构：
[1] Hop Tenon, Med Dev & Training MDT Serv, F-75020 Paris, France
[2] Hop Tenon, Serv Dermatol, F-75020 Paris, France
[3] Celgene, F-75002 Paris, France
[4] Univ Paris Est Creteil, Inserm UMRS 1123, Hop Henri Mondor, AP HP, F-75004 Paris, France
[5] Hop Hotel Dieu, URCEco Ile de France, 1 Pl Parvis de Notre Dame, F-75004 Paris, France
[6] Boehringer Ingelheim GmbH & Co KG, F-51721 Reims, France
[7] Bristol Myers Squibb, F-92500 Rueil Malmaison, France
[8] Univ Paris 05, Hop Cochin, AP HP, GH Broca Cochin Hotel Dieu,Sorbonne Paris Cite, F-75014 Paris, France
[9] Takeda France, F-92977 Paris, France
[10] HEVA HEOR, F-69006 Lyon, France
[11] MSD France, F-92418 Courbevoie, France
[12] Hoffmann La Roche AG, Global Pricing & Market Access, CH-4070 Basel, Switzerland
来源：
THERAPIE | 2016年 / 71卷 / 01期
关键词：
SURROGATE; OUTCOMES;
D O I：
10.1016/j.therap.2015.12.002
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：59 / 67
页数：9
相关论文
共 50 条
  • [1] Progression-free survival, overall survival and quality of life: What is their medicoeconomic importance in oncology?
    Pavlovic, Mira
    Garnier, Jerome
    Durand-Zaleski, Isabelle
    Bilbault, Pascal
    Gaudin, Anne-Francoise
    Le Jeunne, Claire
    Lalaude, Olivier
    Roze, Stephane
    de Sahb, Rima
    Sapede, Claudine
    [J]. THERAPIE, 2016, 71 (06): : 625 - 632
  • [2] OVERALL SURVIVAL VERSUS PROGRESSION-FREE SURVIVAL IN ONCOLOGY CLINICAL TRIALS
    Aissaoui, A.
    Bin Sawad, A.
    Turkistani, F.
    Aissaoui, N.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A717 - A717
  • [3] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Belin, Lisa
    Tan, Aidan
    De Rycke, Yann
    Dechartres, Agnes
    [J]. BRITISH JOURNAL OF CANCER, 2020, 122 (11) : 1707 - 1714
  • [4] THE ASSOCIATION BETWEEN PROGRESSION-FREE SURVIVAL AND OVERALL SURVIVAL IN ONCOLOGY TRIALS: A SIMULATION EXERCISE
    Wu, D. B. C.
    Manjula, I. S.
    Yu, D.
    [J]. VALUE IN HEALTH, 2022, 25 (01) : S198 - S198
  • [5] Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic review
    Lisa Belin
    Aidan Tan
    Yann De Rycke
    Agnès Dechartres
    [J]. British Journal of Cancer, 2020, 122 : 1707 - 1714
  • [6] IMPROVED ESTIMATION OF OVERALL SURVIVAL AND PROGRESSION-FREE SURVIVAL FOR STATE TRANSITION MODELLING IN ONCOLOGY
    Wigfield, P.
    Heeg, B.
    Ouwens, M.
    [J]. VALUE IN HEALTH, 2022, 25 (12) : S6 - S6
  • [7] Impact of interferon maintenance therapy on multiple myeloma patients' quality of life, progression-free survival and overall survival
    Bumeder, I
    Tyroller, M.
    Fischer, N.
    Busch, R.
    Frick, E.
    [J]. PSYCHO-ONCOLOGY, 2006, 15 (02) : S187 - S188
  • [8] Concordance index: Surrogacy of progression-free survival for overall survival
    Fan, Yiwei
    Yin, Guosheng
    [J]. CONTEMPORARY CLINICAL TRIALS, 2021, 104
  • [9] Progression-free survival (PFS) as a surrogate for overall survival (OS)
    Stewart, David J.
    Bosse, Dominick
    Hilton, John
    Goss, Glenwood
    Fung-Kee-Fung, Michael
    Jonker, Derek
    [J]. CANCER RESEARCH, 2018, 78 (13)
  • [10] Quantifying the association between progression-free survival and overall survival in oncology trials using Kendall's τ
    Weber, Enya M.
    Titman, Andrew C.
    [J]. STATISTICS IN MEDICINE, 2019, 38 (05) : 703 - 719
12345